Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study
2015; Elsevier BV; Volume: 126; Issue: 13 Linguagem: Inglês
10.1182/blood-2015-02-629204
ISSN1528-0020
AutoresHiroto Inaba, Yinmei Zhou, Oussama Abla, Souichi Adachi, Anne Auvrignon, H. Berna Beverloo, Eveline de Bont, Tai-Tsung Chang, Ursula Creutzig, Michael Dworzak, Sarah Elitzur, Alcira Fynn, Erik Forestier, Henrik Hasle, Der-Cherng Liang, Vincent Lee, Franco Locatelli, Riccardo Masetti, Barbara De Moerloose, Dirk Reinhardt, Laura Rodríguez, Nadine Van Roy, Shuhong Shen, Takashi Taga, Daisuke Tomizawa, Allen Eng Juh Yeoh, Martin Zimmermann, Susana C. Raimondi,
Tópico(s)Chronic Myeloid Leukemia Treatments
ResumoKey Points AMKL patients in 2000 to 2009 had better survival than those in 1989 to 1999, but outcomes for patients in 2000 to 2004 and 2005 to 2009 were comparable. Heterogeneous cytogenetic groups can be classified into good, intermediate, and poor risk on the basis of prognosis.
Referência(s)